XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Consolidated Statements of Operations and Comprehensive Loss [Abstract]        
Net sales $ 15,990 $ 16,311 $ 42,281 $ 54,449
Cost of sales 6,701 7,462 17,883 23,985
Gross profit 9,289 8,849 24,398 30,464
Operating expenses 10,528 11,254 29,204 31,903
Impairment expense 0 0 1,078 0
Loss from operations (1,239) (2,405) (5,884) (1,439)
Other (income) expense:        
Interest expense 2 0 2 32
Other, net 29 (62) (75) (7)
Total other (income) expense 31 (62) (73) 25
Loss before income taxes (1,270) (2,343) (5,811) (1,464)
Benefit for income taxes (288) (624) (1,316) (390)
Net loss [1] (982) (1,719) (4,495) (1,074)
Foreign currency translation adjustments, net of tax 133 (196) (83) 205
Comprehensive loss $ (849) $ (1,915) $ (4,578) $ (869)
Net loss per common share:        
Basic (in dollars per share) $ (0.11) $ (0.19) $ (0.50) $ (0.12)
Diluted (in dollars per share) $ (0.11) $ (0.19) $ (0.50) $ (0.12)
Weighted average number of shares outstanding:        
Basic (in shares) [1] 9,042,991 8,932,246 9,038,415 8,957,578
Diluted (in shares) [1] 9,042,991 8,932,246 9,038,415 8,957,578
[1] For the three and nine months ended September 30, 2020, there were 1,875 and 7,422 shares, respectively, excluded from the diluted EPS calculation and for the three and nine months ended September 30, 2019, there were 2,704 and 5,200 shares, respectively excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in those respective periods.